Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA

Vere Hodge, R Anthony

The administration core includes Rich Whitley, Mary Wyatt Bowers and Maaike herself. Whereas Rich is the 'glue', Maaike sees herself as the 'glue applicator', able to understand the languages of different disciplines, writing clear meeting notes, identifying action items and arranging for an outside party to interview all interested parties when deciding on inventorship. Also, the need for data has to be explaineddata on ALL compounds are required to determine structure-activity relationships. What measures should be used, 50%, 90% or log 10 reduction of virus replication? What serotype? There must be free exchange of data and engagement of the whole team. When misconceptions arise, it is important to rectify the problem in an open, transparent way. Above all else, it is not sufficient just to safeguard trust but also it is necessary to promote trust by face-to-face meetings which should include fun, social events. ICAR has been used by AD3C to report recent progress, presentations 68, 70, 85, 155 and 172. The underlying aim of Priscilla Yang ( Figure 7 ) and her laboratory is to use small molecules to inhibit or control protein function in order to probe virological processes and validate new antiviral targets. Using viral proteins (VPs) may open up new avenues for antiviral drug discovery. This presentation will focus on a specific target and why it was chosen. Along the way, that target's biochemical and biological function may be better understood.